Your Article Summary
See Latest ArticlesThe inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization
Acta Ophthalmologica, 06/24/09
Habot-Wilner Z et al. - Topically administered bevacizumab at a concentration of 4 mg/ml significantly reduces corneal NV according to both clinical and histopathological evaluations; lower concentrations were less effective on both parameters.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09
Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09
Today in Cornea/Anterior Segment...keeping you current
Receive free subspecialty "5-minute updates" via email
Evidence-based treatment of acute infective conjunctivitis: Breaking the cycle of antibiotic prescribing
Canadian Family Physician, 11/13/09
Effects of amniotic membrane suspension in human corneal wound healing in vitro
Molecular Vision, 11/09/09
Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09